Moreover, this work has identified several novel recurrent mutations in genes not typically associated with lung adenocarcinoma, which are each present in a significant subset of TCGA lung adenocarcinoma patients (Fig. 3a, e.g. IL32, LOC650368, HSD17B7P2 and RPSA). This evidence concerns the gene HSD17B7P2 and lung adenocarcinoma.